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2ABSTRACT 
Affinity-based systems represent a promising solution to control the delivery of therapeutics using 
hydrogels. Here, we report a hybrid system that is based on the peptidic E/K coiled-coil affinity 
pair to mediate the release of gold nanoparticles from alginate scaffolds. On the one hand, the gold 
nanoparticles were functionalized with Ecoil-tagged epidermal growth factor (EGF). The 
bioactivity of the grafted EGF and the bioavailability of the Ecoil moiety were confirmed by EGF 
receptor phosphorylation assays and by capturing the functionalized nanoparticles on a Kcoil-
derivatized surface, respectively. On the other hand, alginate chains were modified with azido-
homoalanine Kcoil (Aha-Kcoil) by azide-alkyne click chemistry. The hybrid system was formed 
by dispersing NPs functionalized with Ecoil-tagged EGF in alginate hydrogels containing either 
0, 10 or 20% of Kcoil-modified alginate (Alg-Kcoil). With 20% of Alg-Kcoil, the release of Ecoil-
functionalized NPs was reduced by half when compared to the release of NPs without Ecoil, 
whereas little to no differences were noticed with either 0 or 10% of Alg-Kcoil. Differential 
dynamic microscopy was used to determine the diffusion coefficient of the NPs, and the results 
showed a decrease in the diffusion coefficient of Ecoil-functionalized NPs, when compared to bare 
pegylated NPs. Altogether, our data demonstrated that the E/K coiled-coil system can control the 
release of NPs in a high Kcoil content alginate gel, opening diverse applications in drug delivery.
KEYWORDS. Coiled-coil, affinity, diffusion, hydrogel, gold nanoparticle, differential dynamic 
microscopy
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31. Introduction
Researchers from numerous fields strive to develop systems that allow for the controlled and 
efficient delivery of therapeutics, especially for long-term release. A number of complementary 
strategies have emerged in that endeavor; they have been applied to many types of therapeutics, 
from hydrophobic molecules to nucleic acids, peptides and proteins. A very popular method 
consists in encapsulating the therapeutic agent in polymeric micro- or nanoparticles.1,2 Release is, 
in this case, governed by particle degradation and passive diffusion of the therapeutic. The 
encapsulation process however tends to degrade peptides and proteins and has therefore been 
primarily applied to small hydrophobic molecules.3 The incorporation of the drug in a polymeric 
scaffold is another frequently encountered strategy, for which the release is mainly regulated by 
scaffold swelling and/or scaffold degradation, be it in bulk or by surface erosion, although passive 
diffusion can play a significant role.4 Affinity-based delivery strategies have recently gained a lot 
of interest as they may offer more versatility and can promote long-term and continuous release of 
drugs or proteins.3 Indeed, by incorporating a specific biological anchor in a polymeric scaffold, 
the molecule diffusion can be dramatically slowed down and thus release can be stretched over a 
long period of time.3,5 These systems have been growing in number and variety, and show potential 
for an increasing number of applications.6–10
Most affinity-based strategies thus far have relied on naturally occurring interactions between the 
protein or drug of interest and one of its biological partners. Glycans such as heparin and sulfates 
have been widely reported as a means to sequester heparin-binding proteins within scaffolds11, 
which has significantly extended the duration of protein delivery up to several days.6,12 Similarly, 
complexes of β-cyclodextrins have been covalently incorporated in hydrogels to control the release 
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4of hydrophobic low molecular weight proteins.13 Some research groups have engineered 
polysaccharide fragments and peptide sequences inspired by natural biomolecules to interact more 
specifically with the therapeutic of interest and/or to better control its delivery.14 For instance, Lin 
et al. were able to control the release profile of a growth factor from a poly(ethylene glycol) (PEG) 
hydrogel by functionalizing PEG chains with affinity binding peptides.7 Similarly, Wang et al. 
developed a competitive affinity-based system to release multiple proteins at different timepoints 
of the treatment.8 More precisely, the vascular endothelial and the platelet-derived growth factors 
were immobilized on polystyrene microparticles using two different aptamers and then those 
microparticles were dispersed in a hydrogel. Protein release could then be triggered by simple 
incubation of a competitive aptamer sequence. Regardless, systems based on natural interactions 
suffer from a lack of versatility. Indeed, most designs only suit a narrow panel of therapeutic 
agents, given that each drug may require its own partner and specific hydrogel characteristics. 
Moreover, the release profiles are dictated by the thermodynamics of the interaction, which are 
hardly tunable for natural partners. The advances in biomolecule design and synthesis, notably by 
protein engineering, may offer a way to circumvent these issues and fulfill the current need for 
more flexibility and finer control of spatiotemporal delivery.
Coiled-coils are a ubiquitous motif found in proteins that has been discovered more than six 
decades ago and has been the core subject of many scientific works. The research based on de 
novo designed coiled-coil forming peptides has led to a robust knowledge of the determinants of 
their interactions.15–17 The rational design of peptide sequences that feature tunable specificity, 
stability and oligomerization state has therefore been dramatically facilitated. It has been exploited 
for various tissue engineering and gene delivery applications,18 and several proteins including 
growth factors, transcription factors and antibodies have been grafted onto polymer-based 
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5structures thanks to coiled-coil complexes.19–22 Our group previously developed two de novo 
designed peptides, namely the Ecoil and the Kcoil, which design is based on the repetitions of 
seven distinct amino acids (a heptad). When mixed together, the peptides spontaneously form a 
coiled-coil heterodimeric complex, which affinity can be modulated by the number of heptads and 
their sequence, especially the aliphatic residues that comprise the hydrophobic core of the 
interaction.23–25 The rationale of this research was to investigate the potential of coiled-coil 
interactions for the preparation of novel hybrid systems, that is, hydrogels that can deliver 
biofunctionalized nanoparticles (e.g. decorated on their surface with proteins or with encapsulated 
drugs), at a speed that is not only dependent on particle diffusion or gel degradation but that is 
tuned by specific affinity interactions. 
To produce such system, we developed an Ecoil-decorated nanoparticle that can interact via 
specific coiled-coil interaction with Kcoil-grafted hydrogel.  More precisely, we report, on the one 
hand, the functionalization of gold nanoparticles (AuNPs) with the Ecoil peptide as well as the 
human epidermal growth factor (EGF) using a cysteine-tagged Ecoil-EGF chimeric protein. 
AuNPs are interesting candidates for their biomedical applications in cancer (radiotherapy26 and 
photothermal therapy27), imaging and drug delivery28. Their surface functionalization with 
therapeutics or peptides is well-documented.28 On the other hand, we report a polymeric scaffold 
made from alginate chains that were covalently modified with the complementary Kcoil peptide 
and designed to specifically interact with decorated AuNPs. Alginate gels indeed feature an 
excellent biocompatibility, a wide use as injectable gels and unique gelation properties.29 The 
AuNPs/hydrogel system was formed by simple coincubation of the Ecoil-bearing nanoparticles 
with the Kcoil-modified alginate chains during gelation. Affinity-based systems have been 
reported for protein release from hydrogels, while nanoparticles have been entrapped within gels 
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6for delayed delivery.5,30 This is however the first report, to the best of our knowledge, that 
combines both strategies, that is, to sequester nanoparticles within a hydrogel and to release them 
in a controlled fashion using a specific affinity interaction.3,31
The characterization of the biofunctionalized nanoparticles was carried out by dynamic light 
scattering (DLS), transmission electron microscopy (TEM) and 1H nuclear magnetic resonance 
(NMR) as well as enzyme-linked immunosorbent assays (ELISA) to assess the bioavailability of 
both the Ecoil and EGF moieties. The impact of Kcoil concentration in the hydrogel on the 
diffusive properties of the AuNPs was then investigated using differential dynamic microscopy 
(DDM) and typical release tests. Both assays indicated that the formation of the Ecoil/Kcoil 
complex significantly hampered the movement of nanoparticles, and thus that this affinity-based 
strategy is suitable to prolong the release of NPs from hydrogels. The biological activity of the 
EGF moiety displayed on the NPs surfaces was also demonstrated by in vitro cellular assays, both 
prior and after their release from the hydrogels.
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72. Experimental
2.1 Materials
Cysteine-tagged Ecoil-EGF (CEE) was produced in HEK 293-6E cells and purified by 
immobilized metal-ion affinity chromatography (IMAC) followed by size-exclusion 
chromatography, as previously described.32 Protein concentration was determined by an enzyme-
linked immunosorbent assay (ELISA) against EGF and analyzed by SDS-PAGE. Purified CEE 
was then stored at -80 °C until use. The azidohomoalanine-terminated Kcoil peptides 
(AhaGG(KVSALKE)5, or Aha-Kcoil) were synthesized by the peptide facility at University of 
Colorado (Denver, CO). Untagged recombinant human EGF and ELISA kit were purchased from 
R&D Systems (Minneapolis, MN). Sodium alginate (MW = 171 kDa) (IL-6G) were purchased from 
Kimica corporation (New-York, NY). Thiolated polyethylene glycol (PEG-SH) (MW = 5 kDa) was 
obtained from Jenkem Technology (Dallas, TX). MilliQ water was generated with a Millipore 
Gradient A10 purification system. Dulbecco’s modified Eagle’s medium (DMEM), fetal bovine 
serum (FBS) and gentamicin were obtained from Gibco (Burlington, VT). 75-cm2 CellBIND flasks 
and 48- and 96-well CellBIND plates for cell cultures were purchased from Corning (Corning, 
NY). All other products and chemicals were purchased from Sigma-Aldrich Canada Ltd. 
(Oakville, ON), unless otherwise specified. Absorbance measurements were carried out on a 
Victor V Multilabel Counter from PerkinElmer Inc. (Woodbridge, ON) or using a Spark® 
multiplate reader from Tecan Group Ltd (Männedorf, Switzerland).
2.2 Biofunctionalization of gold nanoparticles
2.2.1 Synthesis and characterization of gold nanoparticles
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8Gold nanoparticles (AuNPs) were synthesized using a citrate reduction method according to a 
previously published procedure.33 Briefly, trisodium citrate (0.94 mL at 11.4 mg/mL) was rapidly 
injected in a boiling chloroauric solution (50 mL at 0.1 mg/mL in MQ water) under vigorous 
stirring and heating for 5 min, then cooled to room temperature (RT). The color of the solution 
changed from blue to deep red.
The NPs sizes were characterized by dynamic light scattering (DLS) using a Malvern Zetasizer 
(Malvern, UK) and by transmission electron microscopy (TEM, field emission 2100F, JEOL, 
Tokyo, Japan). The number of gold atoms per nanoparticle (N) was estimated using 34
 ,𝑁 = 𝜋6𝜌𝐷3𝑀 (1)
where ρ is the density for face-centered cubic gold (19.3 g/cm3), M is the atomic weight of gold 
(197 g/mol) and D is the diameter of the NPs determined by TEM.
The final AuNPs concentration is given from
 ,[𝐴𝑢𝑁𝑃𝑠] = 𝑚𝑀 × 𝑁 × 𝑉 (2)
where m is the initial mass of gold and V is the final volume of the solution. In our experimental 
conditions, the concentration of the pristine gold nanoparticles was 8.2 1011 particles/mL or 1.4 
nM, and their diameter was 18 ± 2 nm according to TEM. The stock solution was used to determine 
the AuNPs extinction coefficient at 531 nm, i.e. εAuNP = 5.53 108 M-1.cm-1, which is in good 
agreement with the literature for particles of this size.35 After functionalization of the gold 
nanoparticles, the concentration of coated AuNPs was evaluated via UV-Vis measurements at 531 
nm. 
2.2.2 PEGylation of gold nanoparticles
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9After synthesis, the AuNPs were stabilized by means of decoration with a low density of thiolated 
polyethylene glycol (PEG-SH) (Mw = 5 kDa). The gold nanoparticles exposing a low density of 
PEG (NP-PEGLD) were obtained by injecting ca. 7 µL of PEG-SH in 20 mL of the citrate solution 
containing the AuNPs (final concentrations of 0.5 µM PEG-SH and 1.4 nM AuNPs). After 16 h 
under stirring, the NP-PEGLD were centrifuged one time (10,000 × g for 30 min) and the 
supernatant was discarded to remove unreacted PEG-SH.
The amount of PEG-SH on the particles was determined using a 1H NMR-based method as 
previously described.36 Briefly, PEGylated NPs (700 µL, 5.4 nM) were digested overnight with 7 
µL of Aqua Regia solution (37% HCl and 68-70% HNO3 in a 3:1 ratio v/v). The resulting mixture 
was then freeze-dried and resuspended in deuterium oxide (D2O) to reach a final volume of 700 
µL. Acetonitrile (ACN) was used as a standard to quantify the PEG-SH concentrations, i.e. 7 µL 
of 0.24% v/v ACN in water was added to each sample. The PEG-SH concentration was evaluated 
by calculating the ratio between the integration of two peaks at specific positions for PEG-SH (3.7 
ppm) and ACN (2.06 ppm). The PEG-SH concentration of each sample was determined using a 
standard curve ranging from 0.1 to 200 µM of PEG-SH.
2.2.3 Cys-Ecoil-EGF grafting on the pegylated gold nanoparticles
The NP-PEGLD were coated with cysteine-tagged Ecoil-EGF (CEE) thanks to the thiol group 
displayed by the cysteine. NP-PEGLD were mixed with CEE (final concentrations of 1.4 nM and 
500 nM, respectively) in MQ water containing dextran chains that acted as a labware non-specific 
adsorption blocker (10 mg/L of pristine dextran, Mw = 70 kDa). The mixture was allowed to react 
for 16 h under gentle agitation. To enhance NPs stability, PEG-SH was then added at a final 
concentration of 50 µM for 2 h to generate highly dense PEG-coated NPs (NP-PEGHD). Unreacted 
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10
material was removed by performing 4 centrifugations cycles (10,000 × g for 30 min). For each 
cycle, 1.9 mL of supernatant were discarded and the remaining 100 µL of CEE-coated 
nanoparticles (NP-CEE-PEGHD) were resuspended in 1.9 mL of phosphate buffered saline solution 
(PBS, 10 mM sodium phosphate and 150 mM of KCl/NaCl salts) supplemented with 0.1% v/v 
Tween-20 (PBS-T). As controls, NP-PEGLD were incubated with untagged EGF or without added 
EGF and were subjected to the same purification and blocking procedures. The resulting NPs were 
named NP-EGF-PEGHD and NP-PEGHD, respectively. The final amount of PEG-SH grafted on NP 
preparations was determined using the protocol described in the previous section.
2.2.4 EGF quantification
Effectiveness of the CEE grafting on the NPs surface was confirmed by a competitive enzyme-
linked immunosorbent assay (ELISA) against EGF. Polystyrene 96-well plates were first saturated 
with the growth factor overnight (16 h) using 100 µL of 5 nM Ecoil-EGF per well. The wells were 
then blocked with 50 µL of 1% w/v BSA in PBS for 1 h. In parallel, the NP samples were mixed 
1:1 v/v with biotinylated anti-EGF antibodies (100 pM in PBS-T) for 1 h, while known EGF 
concentrations were mixed with antibodies for calibration. 50 µL of the NPs/antibodies mixtures 
were then incubated in the EGF pre-coated wells for 1 h. Detection was performed by adding 50 
µL of horseradish peroxidase (HRP)-streptavidine conjugate for 20 min followed by a revelation 
step using 50 µL of substrate solution. A rinsing step was performed after each incubation (3 
rinsing cycles with 150 µL of PBS-T). Absorbance was read at 630 nm and 531 nm for correction. 
2.3 Bioadhesion of the functionalized nanoparticles
The ability of the Ecoil moiety exposed on the NP-CEE-PEGHD surface to interact with its binding 
partner, the Kcoil, was assessed by immobilizing functionalized NPs on a Kcoil-coated surface. 
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11
Kcoil-bearing dextran surfaces were prepared in 96-well plates as previously described.22 
Functionalized wells were first blocked with BSA (1% w/v in PBS, 100 µL/wells) for 1 h. The 
NP-CEE-PEGHD, NP-EGF-PEGHD and NP-PEGHD were then injected at a concentration of 140 
pM of particles for 1 h. The immobilized NPs were detected using an ELISA against EGF, thanks 
to a protocol adapted from a previously reported work.37 Briefly, 50 µL of biotinylated anti-EGF 
antibodies were added during 30 min. Detection and rinsing steps were carried out as described in 
the previous section.
2.4 Kcoil grafting on alginate
Kcoil peptides were covalently grafted on alginate via an alkyne-azide click chemistry. Sodium 
alginate (1.5 g) was first dissolved in 10 mL of 0.5 M NaOH. 6.5 mL of undiluted glycidyl 
propargyl ether (GPE, 90+% purity) was added and the mixture was allowed to react at RT under 
agitation for 24 h. The product was then dialyzed (cut-off of 8 kDa) against MQ water for 72 h, 
freeze-dried and stored at 4 °C until use.
The azide-terminated Kcoil (Aha-Kcoil) was then grafted on the GPE-modified alginate (Alg-
GPE). 100 mg of Alg-GPE were dissolved in 10 mL of MQ water with finals concentrations of 1 
mM of Tris(3-hydroxypropyltriazolylmethyl)amine (THPTA), 2.5 mM of copper sulfate (CuSO4) 
and 5 mM of sodium ascorbate. Aha-Kcoil was added at an azide:alkyne ratio of 1:40. The mixture 
was then allowed to react at RT for 48 h under agitation and in the dark. Note that after 24 h of 
reaction time, 500 µL of 100 mM sodium ascorbate in MQ water was added in the mixture. Two 
ultrafiltration cycles in a 100 mM EDTA solution followed by three cycles with MQ water were 
carried out using Amicon centrifugal filter (cut-off of 5 kDa). The polymer was then freeze-dried 
and stored at 4 °C until use.
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12
The amount of grafted Kcoil per alginate chain was evaluated by a 2,4,6-Trinitrobenzenesulfonic 
acid solution (TNBS) assay which allows a quantification of the amines on the peptides. The assay 
protocol was adapted from previous work.38,39 Briefly, alginate-Kcoil was diluted at 4 mg/mL in 
sodium bicarbonate (100 mM, pH 8.5). 100 µL of the solution was mixed with 50 µL of TNBS 
(0.01% w/v in sodium bicarbonate, 100 mM, pH 8.5) in a 96-well plate. After 2 h at 37°C, 50 µL 
of sodium dodecyl sulfate (10% w/v in MQ water) and 25 µL of MQ water were added to each 
well. The absorbance was read at 340 nm and 630 nm for reference. A calibration curve was plotted 
using known concentration of glycine (range between 4 and 125 µM) and the molar extinction 
coefficient was corrected by the one for the amine of the lysine side-chain (εglycine=13400 M-1.cm-1 
38 and εlysine=12000 M-1.cm-1).
2.5 NP Release from the alginate matrix
For the NPs release studies, NPs solutions in PBS were mixed with alginate in a 1:1 ratio. More 
precisely, 8.1 nM of NP-CEE-PEGHD and NP-PEGHD were mixed with solutions containing 80-
90% w/w of unmodified alginate plus 10% w/w of GPE-modified, 10% w/w of Kcoil-modified or 
20% w/w of Kcoil-modified alginate (resp. Alg-Kcoil0%, Alg-Kcoil10% and Alg-Kcoil20%) for 
a total of 2% w/v of alginate in water. 50 µL of the mixture (alginate and NPs) were poured in a 
96-well plate and gels were formed by adding 50 µL of CaCl2 (0.1 M in water) for 1 h. CaCl2 was 
then removed and gels were incubated in 200 µL of PBS at RT and under mild agitation (20 RPM). 
At each timepoint (0, 2, 4, 6, 9, 24 and 72 h), gels were removed from the wells and dissolved with 
20 µL of sodium citrate (350 µM). Final volumes were adjusted to 110 µL and the concentration 
of NPs within the samples was determined by absorbance at 531 nm.
2.6 Differential dynamic microscopy (DDM)
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13
NP-CEE-PEGHD and NP-PEGHD were mixed with Alg-Kcoil10%, Alg-Kcoil20% or MQ water in 
an equal volume (final concentration of 8.1 nM of nanoparticles and 1% w/v of alginate). 180 µL 
of the mixtures were injected in 0.4-mm thick glass capillaries (Vitrocom, Canada). Capillaries 
containing alginate were opened on both ends and incubated in a CaCl2 solution (20 mM) for 24 h 
for complete gelation to occur. All capillaries were sealed using petroleum jelly prior to DDM 
experiments.40 DDM is a correlation-based microscopy technique that enables the characterisation 
of particle dynamics in complex systems.41–43 Full details about DDM analysis can be found 
elsewhere44–46 and only an overview is presented below.
Videos were recorded at 100 frames per second for 41 seconds using an upright bright-field 
microscope (Olympus BX81) equipped with a high acquisition-speed camera (Hamamatsu Orca-
Flash 4.0 V3) and a 20X magnification phase contrast objective (Olympus Plan Ph1, NA = 0.4). 
From those movies, power spectrums of the difference between all pairs of images (separated by 
the same delay time ) were calculated and averaged yielding the averaged Differential Image 
Correlation Function . For isotropic motion the azimuthal average was calculated, giving 𝑔(𝑞, 𝜏) 𝑔
 with q being the spatial frequency, which under appropriate imaging (𝑞, 𝜏) =  < 𝑔(𝑞,𝜏) > 𝑞
conditions44–46 is related to the intermediate scattering function  probing for particle 𝑓(𝑞, 𝜏)
dynamics so that:
 ,        (3)𝑔(𝑞,𝜏) = 𝐴(𝑞)(1 ― 𝑓(𝑞,𝑡)) + 𝐵(𝑞)
where A(q) is the amplitude signal and B(q) the background noise. Fitting  with appropriate 𝑔(𝑞, 𝜏)
models of  can access particle dynamics. We used a generalized exponential: 𝑓(𝑞, 𝜏)
       (4)𝑓(𝑞, 𝜏) = 𝑒 ― ( 𝜏𝜏𝑅)𝛽
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where R is the relaxation time and  is an exponent that provides insight about size polydispersity 
of particles and their interactions. For monodisperse non-interacting spheres in water,  and 𝛽 = 1
the relaxation time is , with D being the diffusion coefficient from which the particle 𝜏𝑅 = 1𝑞2𝐷
radius, r, can be extracted following the Stoke-Einstein equation:
                 (5)𝐷 = 𝑘𝑇6𝜋𝑛𝑟 
with kT the thermal energy and n the viscosity.  usually indicates size polydispersity and/or 𝛽 < 1
interactions, be it particle/particle or particle/gel interactions. We found that  was between 0.9 𝛽
and 1 both in water and in the alginate gels, suggesting that interactions were negligible. We 
verified that the relaxation times τR were proportional to q-2, therefore an effective diffusion 
coefficient D could be extracted from τR = q-2D-1. 
2.7 In vitro cell assay
2.7.1 Cell culture
A431 cells overexpressing the EGF receptor were maintained in 75-cm2 flasks using Dulbecco’s 
modified Eagle’s medium (DMEM) supplemented with 10% v/v of fetal bovine serum (FBS) and 
0.1% v/v of penicillin-streptomycin. The flasks were kept in a humidified incubator (37 °C, 5% 
CO2) until 85-90% confluence.
2.7.2 Phosphorylation assay by Western Blot
A431 cells were distributed in 48-well plates at a concentration of 0.6 106 cells/mL (0.5 mL per 
well). 20 h later, 85-90% of confluence was reached and each well was rinsed 2 times with 1 mL 
of PBS. Cells were then starved for 3 h using 500 µL of basal medium (DMEM with no serum). 
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The basal medium was removed from each well and the cells were exposed during 5 min to 50 µL 
of the functionalized NPs (at an equivalent EGF concentration of 1.5 nM, according to ELISA) or 
to 50 µL of soluble EGF (EGF concentrations of 0.1, 1 and 10 nM). The wells were washed twice 
with 1 mL of PBS supplemented with 1 mM of sodium-orthovanadate, and the cells were then  
lysed using 75 µL of a commercial lysis buffer supplemented with 0.1 mM of sodium-
orthovanadate. Insoluble materials were removed by centrifugation (10,000 × g, 20 min, 4 °C). 
Samples were then analysed for phosphotyrosine levels by Western Blot, using mouse PY99 
(Santa Cruz, CA) and anti-mouse-HRP antibodies, according to a previously-reported procedure.47 
A Bradford assay was performed prior to gel electrophoresis to ensure that the same amount of 
protein was loaded in each well. A ChemiDoc system (Biorad, Hercules, CA) and the ImageLab 
software were used to image the nitrocellulose membrane and to analyse images, respectively. 
Quantification of the level of phosphorylation in each well was enabled by the Quantity tools of 
the software, using the signal obtained with soluble EGF (10, 1 and 0.1 nM) as a calibration.
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3. Results and discussion
We here report the engineering of an affinity-based system for the controlled release of 
biofunctionalized NPs from a hydrogel, using the high-affinity E/K coiled-coil interactions. This 
strategy makes use of AuNPs decorated with cysteine-tagged Ecoil-EGF (CEE) and of Kcoil-
derivatized alginate hydrogels. AuNPs were stabilized through PEGylation, both before and after 
CEE functionalization (Figure 1.A), while the Kcoil peptide was grafted on the alginate chains 
using GPE-mediated alkyne:azide click chemistry (Figure 1.B).  We here investigated the diffusive 
properties of the Ecoil-NPs as a function of Kcoil density in alginate hydrogels (Figure 1.C).
Figure 1. Preparation of the affinity-based hybrid system using gold nanoparticles and an 
alginate scaffold. (A) AuNPs were first PEGylated to a low level for stabilization. Cys-Ecoil-
EGF (CEE) was then grafted via thiol-gold chemistry. A second PEGylation step was then 
performed for higher stability. (B) Alginate chains were first derivatized with an alkyne moiety 
using glycidyl propargyl ether (GPE). Azidohomoalanine-tagged Kcoil peptides (Aha-Kcoil) 
were then grafted via azide-alkyne click chemistry. (C) The dispersion of Ecoil-AuNPs in the 
Kcoil-alginate hydrogel enabled the formation of the E/K coiled-coil complex to slow down NPs 
release.
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3.1 Characterization of pristine and functionalized NPs
Pristine and functionalized gold nanoparticles (AuNPs) were characterized using transmission 
electron microscopy (TEM) to determine NPs core diameter, dynamic light scattering (DLS) and 
differential dynamic microscopy (DDM) for hydrodynamic diameter, 1H nuclear magnetic 
resonance (NMR) for PEG density, enzyme-linked immunosorbent assays for EGF density and 
UV-Vis spectroscopy. The data are shown in Table 1 and Figure 2.
Figure 2 : Transmission electron microscopy (TEM) image of AuNPs.
The average NPs diameter measured was 18 ± 2 nm (n=100).
DLS analysis indicated that the average hydrodynamic diameter of the synthesized AuNPs was dh, 
DLS = 28 ± 0 nm with a polydispersity index of PDI = 0.29 ± 0.00. Throughout the functionalization 
process (PEG then CEE then PEG again), the PDI of each NPs type did not significantly change 
(PDI = 0.29 ± 0.01, 0.31 ± 0.02 and 0.29 ± 0.00 for NP-CEE-PEGHD, NP-EGF-PEGHD and NP-
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PEGHD respectively). The hydrodynamic diameter of NP-PEGLD was dh, DLS = 55 ± 3 nm, that is, 
the first PEGylation step induced an increase in diameter of 27 nm, which is in good agreement 
with the literature.48 After CEE grafting and a second PEGylation step, the NPs size further 
increased to reach dh, DLS = 62 ± 2 nm. The increase in size (7 nm) between NP-PEGLD and NP-
CEE-PEGHD indicated that the first low-density PEG layer allowed for both stabilization and 
subsequent functionalization. NPs sizes were also determined by DDM. The diffusion coefficient 
of each type of NPs was first measured in water. NPs sizes were calculated using the Stokes-
Einstein equation (Eq. 5) from the measured NPs diffusion coefficient D. The sizes of NP-CEE-
PEGHD and NP-PEGHD obtained using DDM were close to the values previously determined with 
DLS (cf. Table 1), while the gap between both techniques can be attributed to a different analysis 
of the intermediate scattering function (ISF) to take into account polydispersity effects.44,49 For the 
NP-PEGLD, the average number of PEG chain per NP was calculated at σPEG = 0.2 ± 0.1 thousands 
of PEG chains. Of interest, NP-PEGHD particles had an average number of PEG per NP of σPEG = 
2.6 ± 0.8 whereas NP-CEE-PEGHD and NP-EGF-PEGHD featured dramatically less PEG chains 
per particle (σPEG = 0.8 ± 0.3 and σPEG = 0.5 ± 0.0, respectively), which suggested that the grafting 
of the protein on the NP surface hampered the grafting of PEG chains during the second 
PEGylation step.
The impact of the different functionalization on the NPs physical characteristics was also assessed 
by UV-vis spectroscopy. A significant 4-nm increase in the maximum absorbance wavelength λmax 
was observed between the NP-PEGLD and the fully functionalized NPs. A competitive ELISA was 
developed to determine the average number of EGF protein per NP (corresponding to the EGF 
concentration divided by the NPs concentration). The EGF density, σEGF, was found to be null (0.0 
± 0.0) for the pegylated NP-PEGHD, whereas σEGF reached 1.0 ± 0.6 for NP-CEE-PEGHD. 
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Interestingly, a similar density of σEGF = 1.2 ± 0.0 protein per particle was also obtained for NPs 
that were incubated with untagged EGF (NP-EGF-PEGHD). For this sample, the link between 
untagged EGF and the NP-PEGLD could be attributed to the EGF disulfide bonds interacting with 
the gold surface, as previously proposed by Song et al. 50
Table 1 : Characteristics of bare and functionalized gold nanoparticles.
AuNP NP-PEGLD NP-CEE-PEGHD NP-EGF-PEGHD NP-PEGHD
λmax (nm)a 524 524 528 528 528
dh, DLS (nm)b 28 ± 0 55 ± 3  62 ± 2 64 ± 2 59 ± 2
PDIc 0.29 ± 0.00 0.28 ± 0.00 0.29 ± 0.01 0.31 ± 0.02 0.29 ± 0.00
dh,DDM (nm)d - - 53 ± 2 - 47 ± 0
σPEG (×103)e - 0.2 ± 0.1 0.8 ± 0.3 0.5 ± 0.0 2.6 ± 0.8
σEGFf - - 1.0 ± 0.6 1.2 ± 0.0 0.0 ± 0.0
a Peak absorbance wavelength
b Hydrodynamic diameter determined by DLS (Intensity distribution, mean ± SD, n = 3)
c Polydispersity index determined by DLS (Mean ± SD, n = 3)
d Hydrodynamic diameter determined by DDM (Mean ± SD, n = 5)
e Number of PEG chains per NP (Mean ± SD, n = 3)
f Number of EGF per NP (Mean ± SD, n = 3)
3.2 Bioadhesion and bioactivity of the functionalized AuNPs
The ability of the Ecoil moiety present at the NP-CEE-PEGHD surface to interact with its biological 
partner, the Kcoil peptide, was assessed by incubating the functionalized NPs on Kcoil-decorated 
multiwell plates. After incubation, the immobilized NP-CEE-PEGHD were detected using an HRP-
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labelled anti-EGF antibody. The ELISA data showed a significantly higher signal for NP-CEE-
PEGHD, when compared to NP-EGF-PEGHD and NP-PEGHD for which no signal above the noise 
level was detected (Figure 3.A). The results thus confirmed that a) the Ecoil tag was necessary for 
NP capture on Kcoil-decorated surfaces and that b) the Ecoil moiety was bioavailable, i.e. both 
accessible and functional, on the NP-CEE-PEGHD.
As for the EGF moiety on the NP-CEE-PEGHD surface, its biological activity was evaluated by the 
ability of the growth factor to bind to its cognate receptor (EGFR) and induce EGFR 
phosphorylation. For that purpose, A431 cells were selected as they are known to express high 
levels of EGFR.51 The cells were amplified in DMEM containing 10% v/v FBS until 80-90 % 
confluence. After a 3 h period of starvation in serum-free medium, the cells were stimulated with 
either soluble EGF (0 to 10 nM) or functionalized NPs (apparent EGF concentration of 1.5 nM 
according to ELISA results).  The cells were then lysed, cell debris were removed by centrifugation 
and the amount of phosphorylated EGFR was quantified by Western Blot using an 
antiphosphotyrosine antibody. The EGFR phosphorylation levels were compared to control 
soluble EGF at concentrations ranging between 0 to 10 nM. Results show (Figure 3.B) that NP-
CEE-PEGHD and NP-EGF-PEGHD were able to induce a higher level of EGFR phosphorylation 
when compared to soluble EGF. More precisely, when the NP-CEE-PEGHD and NP-EGF-PEGHD 
particles were diluted to obtain a 1.5 nM concentration of EGF (as determined by ELISA), the 
phosphorylation levels, that is, the degree of cell stimulation, were close to those obtained with a 
soluble EGF concentration of 5 ± 2 nM and 13 ± 2 nM, respectively. Of interest, no signal was 
obtained with NP-PEGHD particles, which confirmed that EGF-free NPs did not induce EGFR 
phosphorylation. The apparently higher biological activity of the NP-tethered EGF could be the 
result of the high proximity of the growth factors on the surface of the particles. Indeed, two 
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proximate EGF are known to promote EGFR dimerization and increase the phosphorylation level 
compared to their isolated counterparts.52
As for the difference between NP-CEE-PEGHD and NP-EGF-PEGHD, it was previously shown that 
the addition of a Cys-Ecoil N-terminal tag to EGF did not alter the biological activity of the protein 
in solution.32 The noticeable difference in EGFR phosphorylation levels obtained with the particles 
decorated with EGF and CEE could thus be attributed to a higher bioavailability (for instance a 
better orientation of the EGFR binding site) of EGF on the NP surface, when compared to CEE. 
The other possible explanation is that the Ecoil, in its random conformation, interacts with EGF 
binding site decreasing its affinity to its receptor.
Altogether, the phosphorylation assay demonstrated that both cysteine-Ecoil-tagged EGF and 
untagged EGF grafted on NP-PEGLD were bioactive, and that their immobilization on NP surface 
did enhance their biological activity. Nonetheless, since our goal is to control the release of NPs 
via the Ecoil/Kcoil interaction, NP-CEE-PEGHD were selected for further characterization given 
that NP-EGF-PEGHD could not interact with Kcoil-modified surfaces (cf. Figure 3.A).
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Figure 3. Bioadhesion and bioactivity of functionalized NPs. 
(A) Bioadhesion on a Kcoil-derivatized surface of NP-CEE-PEGHD, NP-EGF-PEGHD, and NP-
PEGHD as control, as detected by anti-EGF ELISA (n=3) (B) EGFR phosphorylation in A431 
cells upon binding with soluble EGF (10, 1, 0.1 and 0 nM), NP-CEE-PEGHD or NP-EGF-PEGHD 
(EGF concentration of 1.5 nM according to ELISA) and NP-PEGHD , as monitored by Western 
Blot. The 180-kDa band immunoreactive to anti-phosphotyrosine antibodies (corresponding to 
EGFR) was quantified using a ChemiDoc and Image Lab software. Y-axis represents the 
equivalent concentration in soluble EGF (sEGF) (n = 3 for NP-CEE-PEGHD and NP-EGF-PEGHD 
and n = 1 for NP-PEGHD, * indicates statistical differences between datasets (bilateral t-test, p < 
0.05).
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3.3 Characterization of Kcoil grafting on alginate
Kcoil peptides were grafted on the alginate chains using a two-step method, as illustrated in Figure 
4. First, alkyne moieties were conjugated to alginate chain using glycidyl propargyl ether (GPE). 
L-azidohomoalanine (Aha)-terminated Kcoil was then covalently grafted to the polymer using 
alkyne-azide click chemistry.53 In the present experimental conditions, the molar ratio was set to 
1 Aha-Koil for 40 alkyne groups.
The alkyne ratio per chain was first quantified by 1H NMR (Figure 4). A peak distinctly appeared 
at 3.4 ppm (peak A) after the alginate/GPE reaction and was attributed to the proton of the alkyne 
group. Using the peaks at 5.1 and 5.5 ppm as references (peaks M1 and G1, respectively, that were 
attributed to protons held by each alginate monomer),54 we calculated that 29% of the alginate 
monomers were modified with an alkyne group. 
As for the subsequent Kcoil grafting step, the amount of peptide per alginate monomer was 
evaluated thanks to the TNBS-based amine quantification test. Knowing that 1 Kcoil peptide holds 
10 primary amine groups, the TNBS assay revealed that 77 % of the peptides in the alginate-
GPE/Aha-Kcoil mixture reacted with alkyne groups. The yield of this click reaction is in good 
agreement with previous reports that used Aha and alkyne reactive groups.53,55,56 Altogether, the 
171-kDa alginate chains hold an average of 5 Kcoil peptides distributed among the 940 monomers.
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Figure 4. Synthesis and characterization of Kcoil-derivatized alginate.
(A) Alginate was first modified with glycidyl propargyl ether (GPE). Azide-terminated Kcoil 
peptides were then grafted on alginate-GPE via alkyne-azide click chemistry in presence of 
copper sulfate. (B and C) The percentage of alkyne-modified monomers was quantified by 1H 
NMR using the peak at 3.4 ppm (peak A), corresponding to the alkyne, and the peaks at 5.5 ppm 
(G1) and 5.1 ppm (M1) as reference, corresponding to the total amount of monomers.
3.4 Diffusion and release tests
3.4.1 Diffusion of the functionalized NPs
The diffusion of functionalized and pegylated NPs in alginate gels was investigated by DDM. 
Solutions of 2% w/v alginate containing either 10% or 20% w/w of Kcoil-modified alginate were 
mixed in a 1:1 (v/v) ratio with 16.3 pM of either NP-CEE-PEGHD or NP-PEGHD. The mixtures 
were injected in capillaries opened on both ends and were then immersed in a solution of 20 mM 
CaCl2, which initiated the gelation by diffusion of Ca2+ ions. After 24 h, videos were taken at 100 
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fps for 41 s and the results are shown in Figure 5. Intermediate scattering functions (ISFs) f(q,τ) 
were extracted from the autocorrelation function as described above. In the case of Alg-Kcoil10%, 
a second slower dynamic process was observed, that was presumably due to a slow gel drift or the 
presence of a few aggregates as observed from the recorded videos. For such cases, we used a 
double generalised exponential model (from equations 3 and 4) for the ISFs when fitting the DICF 
g(q,τ):
 𝑔(𝑞,𝜏) = 𝐴1(𝑞)(1 ― 𝑓1(𝑞,𝜏)) + 𝐴2(𝑞)(1 ― 𝑓2(𝑞,𝜏)) + 𝐵(𝑞) (6)
where indices 1 and 2 respectively correspond to the short-time (NPs contribution) and long-time 
(aggregate/drift contribution) processes. We only considered the short-time diffusion coefficients 
in what follows.
In Figure 5.A, we express the evolution of the ISF f(q,τ) as a function of the relaxation time R 
rescaled with the spatial frequency q2 to give insight of the dynamic process. This rescaling makes 
the ISFs quantitatively comparable over variable q-ranges for all media considered, when 
considering diffusive process with D = q-2 τR-1. These functions show the same dynamic processes 
for NP-CEE-PEGHD and NP-PEGHD that decorrelate at R q2 ~ 0.11 s/µm2 (D ~ 8-9 µm2/s) in water 
and at R q2 ~ 0.71 s/µm2 (D ~ 1.3-1.5 µm2/s) in Alg-Kcoil10%. However, in Alg-Kcoil20%, ISFs 
corresponding to NP-CEE-PEGHD or NP-PEGHD do not overlap, indicating different diffusion 
coefficient. In all cases, the stretching exponent, β, was found between 0.9 and 1, which implies 
that no significant interaction between the NPs and the gels were observed in DDM. 
From ISFs, τR values were extracted to determine the diffusion coefficient of the NPs in both Alg-
Kcoil10% and Alg-Kcoil20% gels. Diffusion coefficients D were found independent of q, 
suggesting a diffusive motion within alginate gels as depicted in insets of Figure 5.A. The ratios 
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between diffusion coefficients of NPs measured in the gels, D, and in water, Dw, are presented in 
Figure 5.B. 
In Alg-Kcoil10%, no difference in D/Dw was observed between NP-CEE-PEGHD and NP-PEGHD: 
both diffusion coefficients decreased to ca. 14% of the value that was obtained in water. 
Interestingly, for NP-PEGHD, the D/Dw ratio increased from 0.15 ± 0.01 in Alg-Kcoil10% to 0.39 
± 0.07 in Alg-Kcoil20%. This could be due to differences in the structural properties of the 
hydrogels. Indeed, Alg-Kcoil20% has a higher concentration of unreacted hydrophobic alkyne and 
amphipathic Kcoil moieties than Alg-Kcoil10%.
A significant difference between particles was nonetheless observed in Alg-Kcoil20%, where the 
D/Dw of NP-CEE-PEGHD was found to be significantly lower than NP-PEGHD (D/Dw of 0.25 ± 
0.01 and 0.39 ± 0.07, respectively). This observation demonstrates that NP-CEE-PEGHD were 
slowed down by a factor of 4 in Alg-Kcoil20% when compared to water, as opposed to a factor of 
ca. 2.6 for NP-PEGHD. The data thus demonstrated that the specific interaction between Kcoil 
(with sufficient concentration) and Cys-Ecoil-EGF had a significant impact on the diffusive 
properties of nanoparticles.
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Figure 5.  Diffusive properties of NPs assessed by differential dynamic microscopy.
(A) Intermediate scattering function f(q,τ)=exp(-(τ/τR)β) of NP-CEE-PEGHD (red circles) and NP-
PEGHD (black squares) in water, Alg-Kcoil10% and Alg-Kcoil20%. In Alg-Kcoil10%, ISF were 
calculated using a double exponential as in Eq.6. Insets represent the coefficient diffusion D 
(averaged from 5 videos) vs q for each type of NPs. Different q-values were used for each 
medium to best represent the short-time plateau and the long-time plateau of the ISF. (B) 
Diffusion coefficients of NP-CEE-PEGHD and NP-PEGHD, as determined by DDM. The Y-axis 
represents the ratio between the coefficients of diffusion of NPs in the hydrogels, D, and in 
water, Dw. * indicates statistical differences between datasets (n = 5) (bilateral t-test, p < 0.05).
3.4.2 NPs release from biofunctionalized hydrogels
The diffusive properties of the particles in hydrogels were further investigated in release studies. 
NP-CEE-PEGHD and NP-PEGHD particles were added to a 1% (total w/v) alginate solution 
containing 80-90% (w/v) of unmodified alginate supplemented with 10% of Alg-GPE, 10% of 
Alg-Kcoil or 20% of Alg-Kcoil, respectively referred to as Alg-Kcoil0%, Alg-Kcoil10% and Alg-
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Kcoil20%. The solutions were poured in multiwell plates and gelled by the addition of CaCl2 for 
1 h. After gel formation, each gel was incubated in PBS. The concentration of AuNPs that were 
released in the incubation medium was indirectly assessed at different timepoints by measuring 
the number of NPs still entrapped in the hydrogels (Figure 6).
As a starting point, we observed the release profiles of NP-PEGHD in different alginate medium. 
We found that their release was slightly affected by the gel composition, where the higher the 
Kcoil concentration was (from 0% to 10% and to 20%), the faster the NP-PEGHD particles were 
released. This increase in release rate was observed since the first day, with respectively 68.4, 78.7 
and 86.0% of NP-PEGHD released after 24 h, in qualitative agreement with the DDM results 
(Figure 5). As mentioned, we ascribe this difference by the presence of Kcoil and/or the unreacted 
alkyne moieties altering the structural properties (porosity) of the gel. Indeed, chains pending from 
the alginate skeleton can affect crosslinking by preventing the alignment of the alginate chains and 
thus the formation of the so-called “egg box” structure by which alginate crosslinks with calcium 
cations.57 The mechanical properties of the hydrogels were thus investigated using an indentation 
assay. A decreasing trend between Alg-Kcoil0%, Alg-Kcoil10% and Alg-Kcoil20% was observed, 
with Young’s modulus values of 360, 215 and 137, respectively. The data thus suggested that 
mechanical cohesion of the gel decreased with an increasing amount of GPE content (see 
Supplementary Information, Figure S1).
For NP-CEE-PEGHD, the general trend observed in the release profile studies was opposite to the 
one obtained with NPs that bore PEG moieties only. Indeed, there was no increase of NP-CEE-
PEGHD release from Alg-Kcoil0% to Alg-Kcoil20% during the first 9 h. Moreover, after 24 h on, 
the fraction of NP-CEE-PEGHD that was retained inside the gels was significantly higher in the 
Alg-Kcoil20% hydrogel than in hydrogels with lower Kcoil content. More precisely, 42 ± 3 % of 
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the NP-CEE-PEGHD diffused out of the Alg-Kcoil20% hydrogel to the surrounding PBS medium 
after 24 h, while 63 ± 4 % and 62 ± 8 % of the particles were released from Alg-Kcoil10% and 
Alg-Kcoil0%, respectively (Figure 5). In Alg-Kcoil20% at 24 h, Ecoil-decorated nanoparticles, 
NP-CEE-PEGHD, were retained twice as much as the nanoparticles with PEG only (42% and 86% 
of release, respectively). Interestingly, there were no statistically significant differences between 
NP-CEE-PEGHD and NP-PEGHD in Alg-Kcoil0% at any timepoint (n ≥ 4, p > 0.05). This showed 
that (a) the surface presentation of Cys-Ecoil-EGF had no detectable influence on NPs release in 
absence of Kcoil and that (b) differences in NPs surface chemistry did not affect the structure of 
the gel. The variations in release fraction between NP-PEGHD and NP-CEE-PEGHD in the Kcoil-
containing hydrogels could therefore not be attributed to CEE/alginate interactions but rather 
confirmed that the surface presentation of the Ecoil-tagged protein hindered the mobility and 
decreased the release of nanoparticles via the formation of the Ecoil/Kcoil complex.  
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Altogether, the data revealed that the introduction of the Kcoil peptide in the hydrogel and its Ecoil 
partner on the nanoparticles slowed down the release of particles thanks to specific Ecoil/Kcoil 
interactions, despite conflicting changes in the bulk properties of the gel. So to understand the 
mechanism behind NP release, the experimental NPs release curves were fitted using a power-law 
model as described by Ritger and Peppas:58,59 
Figure 6. NPs release from Kcoil-modified alginate hydrogels. NP-CEE-PEGHD (A) and NP-
PEGHD (B) are released from Alg-Kcoil0%, Alg-Kcoil10% and Alg-Kcoil20%, as calculated 
from the number of NPs still entrapped in the gel relative to t = 0. NP-CEE-PEGHD (C) and NP-
PEGHD (D) data were fitted with a power-law model: each exponent was found to be between 
0.43 and 1, characteristic of diffusion (both Fickian and non-Fickian), except for NP-CEE-
PEGHD in Alg-Kcoil20%. (n≥4)
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 ,𝑦 = 𝑘𝑡𝑛 (6)
where y is the fractional solute release, k is a constant, t the release time and n is the diffusional 
exponent. The fitted parameters are shown in Table 2.
In all but one case, diffusional exponents were found between 0.43 and 1, which is characteristic 
of a purely diffusive mechanism (0.43 being purely Fickian and ]0.43;1[ describing an anomalous 
transport, i.e. a mix of Fickian and non-Fickian diffusions). For NP-CEE- PEGHD in Alg-Kcoil20% 
only, a diffusional exponent n of 0.25 was calculated, which means that the power-law model 
cannot be applied and that the release mechanism cannot be explained by diffusion only. In that 
specific case, it was thus apparent that another mechanism was contributing to the release of the 
particles, most likely the specific Ecoil/Kcoil interaction.
It is also worth mentioning that the initial burst release of NP-CEE-PEGHD was both larger and 
longer in Alg-Kcoil10% (ca. 60% of total NPs between 0 and 9 h) than in Alg-Kcoil20% (ca. 40% 
of total NPs within 6 h, Figure 5.A). Following this burst, the behavior of the particles in all three 
gels was highly similar: little to no particle release from 12 to 24 h, then a slow and steady release 
with the same apparent rate between 24 and 72 h (36 to 39% of particle loss). The release rates 
measured after 24 h could be explained by gel erosion (which was noticed when manipulating the 
gels). Indeed, nanoparticles could be released along with the alginate chains whether they 
contained Kcoil moieties or not. This would have also occurred in hydrogels containing NP-
PEGHD, even though it would have been difficult to observe given that the amount released at 24 
h was already very high (ca. 85%). When comparing NP-CEE-PEGHD with NP-PEGHD in Alg-
Kcoil20%, the release mechanism thus appeared as two-fold: first, a slow release of particles 
Page 31 of 48
ACS Paragon Plus Environment
Biomacromolecules
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
32
decorated with Ecoil moieties only, thanks to Ecoil/Kcoil interactions, and second, gel erosion that 
caused the release of NP-CEE-PEGHD to catch up with the release of NP-PEGHD. 
 
Table 2: Results of the fitting parameters obtained using Eq. 6
NP-CEE-PEGHD NP-PEGHD
n k R2 n k R2
Alg-Kcoil0% 0.65 0.12 1.00 0.68 0.12 0.89
Alg-Kcoil10% 0.77 0.11 0.96 0.43 0.27 0.95
Alg-Kcoil20% 0.26 0.21 0.72 0.50 0.28 0.89
n: exponent of the power-law, included between 0.43 and 1 for the model
k: multiplication factor of the Power Law
R2: determination coefficient of the fittings
Parameters were fitted using a linear regression on ln(y) = f(ln(t))
Altogether, both DDM and release tests demonstrated that coiled-coil interactions have a 
significant impact on the diffusive properties of the nanoparticles in hydrogels by slowing their 
release, from the combination of the structure of the gel and coil interactions. DDM was found to 
be a useful predictor of the release flux of NPs in gels by characterizing their diffusion coefficient 
D and correlating it to actual release of NPs.
3.4.3 Bioactivity of released NPs 
To assess the biological potency of the NPs that were first entrapped in gels then released in PBS 
(for a total of 72 h spent in the multiwell plate), an EGFR phosphorylation assay was conducted 
as previously described. The NP-CEE-PEGHD that were collected after their release showed a 
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strong phosphorylation induction, to an extent highly similar to fresh NPs and equivalent to 4.4 
nM of soluble EGF (to be compared with 4.9 nM for fresh particles, cf. Figure 3).This experiment 
highlighted that the bioactivity of the EGF moiety on the surface of the released NP remained 
unaffected by the trapping and release process, critical to achieve any desired therapeutic response. 
This further strengthened our confidence in coiled-coil affinity-based drug delivery system as 
versatile tool to deliver, in a timely manner, nanoparticles to a specific tissue, as here explored for 
cells expressing EGF receptors.
4. Conclusions
Herein we report the use of coiled-coil interactions to extend the release rate of EGF-decorated 
gold nanoparticles from an alginate hydrogel. The proposed approach relies on the covalent 
grafting of the Ecoil peptide on NPs and its complementary partner, the Kcoil, on alginate chains. 
As a proof of concept, we showed that, when compared to AuNPs with PEG only, AuNPs 
decorated with both the Ecoil peptide and the epidermal growth factor were released more slowly 
from hydrogels that featured a high Kcoil peptide content. The released AuNPs were still able to 
induce EGFR-receptor activation via surface-grafted EGF.
To the best of our knowledge, we here showed for the first time that the delivery of a bioactive cue 
can be controlled by using an affinity-based hybrid system, that is, a nanoparticular carrier 
entrapped within a hydrogel using specific affinity interactions. This strategy offers a wide range 
of applications. Gold NPs have indeed been widely used in photothermal therapy, radiotherapy, 
imaging and drug delivery. This system could also be applied to other types of nanoparticles (e.g. 
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liposomes or polymeric NPs) for the delivery of either hydrophilic or hydrophobic drugs. Indeed, 
the use of coiled-coil peptides provides a high level of versatility, as these peptides are highly 
stable and can be grafted on virtually any molecule or structure. Moreover, the rationale design of 
the peptide sequences should allow for a high level of tunability in the thermodynamics of the 
interaction and therefore in the release rates of the therapeutics of interest.
ASSOCIATED CONTENT
Supporting Information: Mechanical properties of alginate hydrogels (indentation assays) and 
estimation of pore size.
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 Figure 1. Preparation of the affinity-based hybrid system using gold nanoparticles and an alginate scaffold. 
(A) AuNPs were first PEGylated to a low level for stabilization. Cys-Ecoil-EGF (CEE) was then grafted via 
thiol-gold chemistry. A second PEGylation step was then performed for higher stability. (B) Alginate chains 
were first derivatized with an alkyne moiety using glycidyl propargyl ether (GPE). Azidohomoalanine-tagged 
Kcoil peptides (Aha-Kcoil) were then grafted via azide-alkyne click chemistry. (C) The dispersion of Ecoil-
AuNPs in the Kcoil-alginate hydrogel enabled the formation of the E/K coiled-coil complex to slow down NPs 
release. 
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 Figure 2 : Transmission electron microscopy (TEM) image of AuNPs. 
The average NPs diameter measured was 18 ± 2 nm (n=100). 
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 Figure 3. Bioadhesion and bioactivity of functionalized NPs. 
(A) Bioadhesion on a Kcoil-derivatized surface of NP-CEE-PEGHD, NP-EGF-PEGHD, and NP-PEGHD as 
control, as detected by anti-EGF ELISA (n=3) (B) EGFR phosphorylation in A431 cells upon binding with 
soluble EGF (10, 1, 0.1 and 0 nM), NP-CEE-PEGHD or NP-EGF-PEGHD (EGF concentration of 1.5 nM 
according to ELISA) and NP-PEGHD , as monitored by Western Blot. The 180-kDa band immunoreactive to 
anti-phosphotyrosine antibodies (corresponding to EGFR) was quantified using a ChemiDoc and Image Lab 
software. Y-axis represents the equivalent concentration in soluble EGF (sEGF) (n = 3 for NP-CEE-PEGHD 
and NP-EGF-PEGHD and n = 1 for NP-PEGHD, * indicates statistical differences between datasets (bilateral 
t-test, p < 0.05). 
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 Figure 4. Synthesis and characterization of Kcoil-derivatized alginate. 
(A) Alginate was first modified with glycidyl propargyl ether (GPE). Azide-terminated Kcoil peptides were 
then grafted on alginate-GPE via alkyne-azide click chemistry in presence of copper sulfate. (B and C) The 
percentage of alkyne-modified monomers was quantified by 1H NMR using the peak at 3.4 ppm (peak A), 
corresponding to the alkyne, and the peaks at 5.5 ppm (G1) and 5.1 ppm (M1) as reference, corresponding 
to the total amount of monomers. 
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 Figure 5.  Diffusive properties of NPs assessed by differential dynamic microscopy. 
(A) Intermediate scattering function f(q,τ)=exp(-(τ/τR)β) of NP-CEE-PEGHD (red circles) and NP-PEGHD 
(black squares) in water, Alg-Kcoil10% and Alg-Kcoil20%. In Alg-Kcoil10%, ISF were calculated using a 
double exponential as in Eq.6. Insets represent the coefficient diffusion D (averaged from 5 videos) vs q for 
each type of NPs. Different q-values were used for each medium to best represent the short-time plateau 
and the long-time plateau of the ISF. (B) Diffusion coefficients of NP-CEE-PEGHD and NP-PEGHD, as 
determined by DDM. The Y-axis represents the ratio between the coefficients of diffusion of NPs in the 
hydrogels, D, and in water, Dw. * indicates statistical differences between datasets (n = 5) (bilateral t-test, 
p < 0.05). 
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 Figure 6. NPs release from Kcoil-modified alginate hydrogels. NP-CEE-PEGHD (A) and NP-PEGHD (B) are 
released from Alg-Kcoil0%, Alg-Kcoil10% and Alg-Kcoil20%, as calculated from the number of NPs still 
entrapped in the gel relative to t = 0. NP-CEE-PEGHD (C) and NP-PEGHD (D) data were fitted with a power-
law model: each exponent was found to be between 0.43 and 1, characteristic of diffusion (both Fickian and 
non-Fickian), except for NP-CEE-PEGHD in Alg-Kcoil20%. (n≥4) 
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